Market Size of Global Gastrointestinal Stent Industry
| Study Period | 2019 - 2029 |
| Base Year For Estimation | 2023 |
| CAGR | 4.90 % |
| Fastest Growing Market | Asia Pacific |
| Largest Market | North America |
| Market Concentration | Medium |
Major Players
*Disclaimer: Major Players sorted in no particular order |
Need a report that reflects how COVID-19 has impacted this market and its growth?
Gastrointestinal Stent Market Analysis
The gastrointestinal Stent Market is poised to grow at a CAGR of 4.9% over the forecast period.
The COVID-19 pandemic has significantly affected the market studied as a result of restrictions on non-emergency procedures during the pandemic. According to a study published by Matthew D Rutter in July 2020, a weekly average of 35,478 endoscopy procedures were performed in the pre-COVID period. Activity in the COVID-impacted period reduced to 12% of pre-COVID levels, and at its lowest point, activity was only 5%. However, at the end of the study period, the procedures were recovering up to 20%. Similarly, according to the article published by author Amrita Sethi in August 2020, in New York, by the third week of the pandemic, the large hospital systems were 40-80% filled with COVID patients, with up to 25% requiring intensive care unit (ICU) care in some locations. On average, GI services in these hospitals decreased their procedural volume by 80 to 90%, and the consultative volume by 50%. Hence, due to the decreased number of gastrointestinal procedures during the pandemic, the growth of the market studied was hampered. However, with the pandemic in control, it is believed that the market will be gaining its pace shortly.
Furthermore, the increasing prevalence of gastrointestinal diseases coupled with aging population is contributing largely to the market growth. For instance, the Crohn's & Colitis Foundation, in 2020, estimated that two-thirds to three-quarters of those with Crohn's disease would have one or more operations in the course of their lifetime. About 30% of surgical patients would have a flare-up within 3 years, and 80% would have one within 20 years. This data indicates that in case of Crohn's disease, surgery is essential which requires GI stents. Hence, with the increasing prevalence of crohn's disease, the market studied will witness a strong growth. Additionally, according to Celiac Disease Foundation, in 2020, the prevalence of celiac disease was 0.4% in South America, 0.5% in Africa and North America, 0.6% in Asia, and 0.8% in Europe and Oceania. The prevalence was higher in female than male individuals and was significantly greater in children than in adults. In conclusion, the prevalence of celiac disease varies with sex, age, and location. Therefore, with the increasing prevalence of gastrointestinal diseases such as Celiac disease, the market studied is expected to witness strong growth over the forecast period.
Gastrointestinal Stent Industry Segmentation
As per the scope of the report, gastrointestinal stents are used for the management of obstructive symptoms in the GI tract, which can arise due to diseases of the GI tract, such as malignancies of the stomach, esophagus, duodenum, and pancreas. The Gastrointestinal Stent Market is segmented by Product Type (Biliary Stent, Colonic Stent, Duodenal Stent, Esophageal Stent, and Pancreatic Stent), Application (Biliary Disease, Colorectal Cancer, Stomach Cancer, Inflammatory Bowel Disease, Other Applications), and Geography (North America, Europe, Asia-Pacific, Middle East and Africa, and South America). The market report also covers the estimated market sizes and trends for 17 different countries across major regions, globally. The report offers the value (in USD million) for the above segments.
| By Product Type | |
| Biliary Stent | |
| Colonic Stent | |
| Duodenal Stent | |
| Esophageal Stent | |
| Pancreatic Stent |
| By Application | |
| Biliary Disease | |
| Colorectal Cancer | |
| Stomach Cancer | |
| Inflammatory Bowel Disease | |
| Other Applications |
| Geography | ||||||||
| ||||||||
| ||||||||
| ||||||||
| ||||||||
|
Global Gastrointestinal Stent Market Size Summary
The gastrointestinal stent market is anticipated to experience steady growth over the forecast period, driven by the increasing prevalence of gastrointestinal diseases and an aging population. The market faced significant challenges during the COVID-19 pandemic due to restrictions on non-emergency procedures, which led to a substantial decrease in gastrointestinal procedures. However, as the pandemic situation has improved, the market is expected to regain momentum. The rising incidence of conditions such as Crohn's disease and celiac disease, which often require surgical interventions involving GI stents, is a key factor contributing to market expansion. Additionally, the growing awareness and diagnosis of colorectal cancer, particularly in developed regions, further bolster the demand for gastrointestinal stents.
North America is projected to dominate the gastrointestinal stent market, supported by its advanced medical device industry, favorable reimbursement policies, and a significant aging population. The region's market growth is also fueled by the increasing prevalence of obstructive gastrointestinal diseases and the presence of major market players. The market is moderately competitive, with several global and local companies, including Boston Scientific Corporation, CONMED Corporation, and Olympus Corporation, actively participating. Innovations such as Olympus's launch of the HANAROSTENT Esophagus Through-the-Scope Stent highlight the ongoing advancements in the field. Despite the short-term impact of COVID-19, the long-term outlook for the gastrointestinal stent market remains positive, driven by technological advancements and the rising demand for minimally invasive surgical options.
Global Gastrointestinal Stent Market Size - Table of Contents
-
1. MARKET DYNAMICS
-
1.1 Market Overview
-
1.2 Market Drivers
-
1.2.1 Rising Prevalence of Gastrointestinal Cancer
-
1.2.2 Growing Geriatric Population and Age Associated GI Disorders
-
1.2.3 Increasing Preference for Minimally-invasive Procedures
-
-
1.3 Market Restraints
-
1.3.1 High Risk of Complications
-
1.3.2 Stringent Regulatory Environment
-
-
1.4 Porter's Five Force Analysis
-
1.4.1 Threat of New Entrants
-
1.4.2 Bargaining Power of Buyers/Consumers
-
1.4.3 Bargaining Power of Suppliers
-
1.4.4 Threat of Substitute Products
-
1.4.5 Intensity of Competitive Rivalry
-
-
-
2. MARKET SEGMENTATION (Market Size - Value in USD million)
-
2.1 By Product Type
-
2.1.1 Biliary Stent
-
2.1.2 Colonic Stent
-
2.1.3 Duodenal Stent
-
2.1.4 Esophageal Stent
-
2.1.5 Pancreatic Stent
-
-
2.2 By Application
-
2.2.1 Biliary Disease
-
2.2.2 Colorectal Cancer
-
2.2.3 Stomach Cancer
-
2.2.4 Inflammatory Bowel Disease
-
2.2.5 Other Applications
-
-
2.3 Geography
-
2.3.1 North America
-
2.3.1.1 United States
-
2.3.1.2 Canada
-
2.3.1.3 Mexico
-
-
2.3.2 Europe
-
2.3.2.1 Germany
-
2.3.2.2 United Kingdom
-
2.3.2.3 France
-
2.3.2.4 Italy
-
2.3.2.5 Spain
-
2.3.2.6 Rest of Europe
-
-
2.3.3 Asia-Pacific
-
2.3.3.1 China
-
2.3.3.2 Japan
-
2.3.3.3 India
-
2.3.3.4 Australia
-
2.3.3.5 South Korea
-
2.3.3.6 Rest of Asia-Pacific
-
-
2.3.4 Middle-East and Africa
-
2.3.4.1 GCC
-
2.3.4.2 South Africa
-
2.3.4.3 Rest of Middle-East and Africa
-
-
2.3.5 South America
-
2.3.5.1 Brazil
-
2.3.5.2 Argentina
-
2.3.5.3 Rest of South America
-
-
-
Global Gastrointestinal Stent Market Size FAQs
What is the current Global Gastrointestinal Stent Market size?
The Global Gastrointestinal Stent Market is projected to register a CAGR of 4.90% during the forecast period (2024-2029)
Who are the key players in Global Gastrointestinal Stent Market?
Olympus Corporation, Boston Scientific Corporation, Hobbs Medical Inc., Conmed Corporation and Becton Dickinson and Company are the major companies operating in the Global Gastrointestinal Stent Market.
